Preparation method of temperature / pH response type hydrogel PDAE and application in drug release

Through the preparation of temperature/pH-responsive hydrogel PDAE, combined with 5-fluorouracil, the problems of traditional drug release control and biocompatibility are solved, and the precise drug release in different environments is achieved, which improves the utilization rate of drugs and biological efficiency of drugs. Compatibility.

CN119039508APending Publication Date: 2024-11-29NORTH CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411161332.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-22
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

Traditional oral chemotherapy drugs are highly toxic, low utilization rate and easily affected by food. Traditional hydrogels have defects in drug release control and biocompatibility, and cannot accurately target and effectively release drugs.

Method used

The temperature/pH-responsive hydrogel PDAE was prepared by copolymerization of DEA and AMPS, combined with EGDMA and APS/TEMED initiator, and the temperature and pH sensitivity were prepared and combined with 5-fluorouracil. , realize the controlled release of drugs.

Benefits of technology

The prepared temperature/pH responsive hydrogel PDAE has good drug-carrying and drug release capabilities, and can accurately control drug release under different temperature and pH environments, improving the biocompatibility and utilization of drugs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119039508A_ABST
    Figure CN119039508A_ABST
Patent Text Reader

Abstract

The invention discloses a temperature / pH response type hydrogel PDAE preparation method and application in drug release, and relates to the field of chemical drug synthesis, DEA and AMPS with a certain amount of substance sum are dissolved in 4 mL of deionized water, EGDMA is dissolved in 4 mL of absolute ethyl alcohol, the two solutions are mixed and ultrasonically dispersed uniformly, and the mixture is placed in an ice bath; slowly adding an APS / TEMED composite initiator, uniformly mixing, transferring into a vacuum needle tube, and fully reacting in a water bath at 45 DEG C for 12 hours; after the polymerization reaction is finished, slowly pushing out the hydrogel by using a piston, then cutting into a cylindrical gel block with the thickness of 3mm, soaking the gel block in deionized water for 72 hours, changing water once every 8 hours to remove unreacted monomers in the system, and then freeze-drying for 48 hours. The hydrogel PDAE prepared by the method has good drug loading and releasing performance.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of chemical drug synthesis, and in particular to a temperature / pH responsive hydrogel PDAE method and its application in drug release. Background Art

[0002] Oral chemotherapy drugs have the disadvantages of high toxicity, low utilization rate and easy to be affected by food, which limits their clinical application. Traditional hydrogels have the functions of transportation and drug delivery, but lack the controlled release of drugs. In addition, traditional hydrogels have the disadvantages of poor biocompatibility. Smart hydrogels can respond to stimuli such as temperature, pH, reactive oxygen species (ROS), glutathione, etc. of normal tissues and diseased tissues in organisms, and have received extensive attention and research in the biomedical field. Compared with single stimulus response systems, dual or multiple stimulus response systems can be more accurately targeted, and each stimulus can be fine-tuned independently to meet the controlled release of drugs. Therefore, the development of smart hydrogels with good biocompatibility and multiple responses is of great practical significance.

[0003] The molecular structure of N,N-diethylacrylamide (DEA) contains hydrophobic groups (diethyl) and hydrophilic groups (amide groups), and its critical temperature (LCST) is 32°C. Changes in temperature affect the hydrophilic and hydrophobic interactions and hydrogen bonding of the groups, so the polymer PDEA formed is temperature sensitive. When DEA is copolymerized with hydrophilic monomers, the interaction between the polymer and water can be changed, thereby obtaining a hydrogel that responds intelligently to the environment. 2-Acrylamido-2-methylpropanesulfonic acid (AMPS) is a hydrophilic vinyl monomer with nonionic and anionic groups. The sulfonic acid group in the AMPS molecular structure can dissociate in a wide pH range and undergo ionization and deionization reactions in different pH environments. Due to the repulsive effect of charges between gel networks, AMPS hydrogels have different swelling behaviors in different pH environments. Summary of the invention

[0004] The purpose of the present invention is to prepare a temperature / pH responsive hydrogel PDAE and provide its application in drug release.

[0005] The present invention adopts the following technical scheme: a method for preparing a temperature / pH responsive hydrogel PDAE, and preparing one unit of the gel in proportion, comprising the following steps: dissolving DEA and AMPS with a certain sum of substance amounts in 4 mL of deionized water, dissolving EGDMA in 4 mL of anhydrous ethanol, mixing the two solutions and uniformly dispersing them by ultrasonication, and then placing them in an ice bath; then slowly adding an APS / TEMED composite initiator, transferring the mixture to a vacuum needle tube after uniform mixing, and fully reacting it in a water bath at 45°C for 12 hours; after the polymerization reaction is completed, slowly pushing out the hydrogel with a piston, and then cutting it into cylindrical gel blocks with a thickness of 3 mm, soaking the gel blocks in deionized water for 72 hours, changing the water every 8 hours to remove unreacted monomers in the system, and then freeze-drying them for 48 hours.

[0006] Furthermore, the sum of the amounts of DEA and AMPS substances is 130 mol.

[0007] Furthermore, the specific dosage of each component is as follows: DEA:AMPS is 121 mol:9 mol; EGDMA is 0.3 g; APS is 50 mg; TEMED is 60 μL.

[0008] Furthermore, the temperature / pH responsive hydrogel PDAE combined with 5-fluorouracil, 5-Fu@PDAE5, was used in drug release.

[0009] Beneficial effects of the present invention: The present invention prepares a temperature / pH responsive hydrogel PDAE, which has certain temperature and pH sensitivity and ion responsiveness. Combined with 5-fluorouracil, 5-Fu@PDAE5 has good drug loading and release capabilities. BRIEF DESCRIPTION OF THE DRAWINGS

[0010] Figure 1 Synthesis route of P(DEA-AMPS-EGDMA) hydrogel;

[0011] Figure 2 IR spectra of DEA, AMPS, EGDMA and PDAE;

[0012] Figure 3 TG graphs of PDAE1 to PDAE7;

[0013] Figure 4 SEM images of PDAE1 to PDAE5;

[0014] Figure 5 SEM images of PDAE5 to PDAE7;

[0015] Figure 6 Porosity maps of PDAE1 to PDAE7;

[0016] Figure 7Swelling kinetics of PDAE1~PDAE7 hydrogels in deionized water, (a) - Swelling kinetics of PDAE1~PDAE5 hydrogels; (b) - Swelling kinetics of PDAE5~PDAE7 hydrogels.

[0017] Figure 8 Changes in swelling ratio of PDAE1 to PDAE5 hydrogels with temperature;

[0018] Fig. 9 The swelling ratio of PDAE1 to PDAE5 hydrogels changes at different pH;

[0019] Fig.10 Drug loading performance test diagram of PDAE1~PDAE7 hydrogel for 5-Fu, (a) - drug loading capacity; (b) - maximum encapsulation efficiency;

[0020] Fig.11 In vitro release curve of 5-Fu@PDAE5. DETAILED DESCRIPTION

[0021] Embodiment 1:

[0022] First, a certain amount of DEA and AMPS were dissolved in 4 mL of deionized water, and EGDMA was dissolved in 4 mL of anhydrous ethanol. The two solutions were mixed and ultrasonically dispersed evenly, and then placed in an ice bath; then the APS / TEMED composite initiator was slowly added, mixed evenly, and transferred to a vacuum needle tube, and fully reacted in a 45°C water bath for 12 hours. After the polymerization reaction was completed, the hydrogel was slowly pushed out with a piston, and then cut into cylindrical gel blocks with a thickness of 3 mm. The gel blocks were soaked in deionized water for 72 hours, and the water was changed every 8 hours to remove the unreacted monomers in the system, and then freeze-dried for 48 hours.

[0023] The sum of the amounts of DEA and AMPS substances was constant, and the contents of different monomers and cross-linking agents were changed. Seven temperature / pH responsive hydrogel PDAEs with different monomer ratios were synthesized using a redox initiation system. The synthesis route is shown in Figure 1 The feed amount of each component is shown in Table 1.

[0024] Table 1 Feeding amount of each component of PDAE1-PDAE7 hydrogel

[0025]

[0026] The infrared spectroscopy analysis of DEA, AMPS, EGDMA and PDAE was performed using the KBr tablet method. The results are as follows: Figure 2 shown.

[0027] In the DEA spectrum, 2975 cm -1 、1363cm -1It is the asymmetric stretching vibration absorption peak and bending vibration absorption peak of CH in -CH3, 2876cm -1 、1448cm -1 It is the symmetrical stretching vibration peak and bending vibration absorption peak of CH in -CH2, 1649cm -1 The peak at 1262 cm is the overlapping peak of the stretching vibration peak of C=O and C=C, which are unique to tertiary amides. -1 It is the stretching vibration peak of tertiary amide CN. In the AMPS infrared spectrum, 1661cm -1 It is the C=C stretching vibration peak, 1547cm -1 It is the CNH bending vibration absorption peak of secondary amide, 1236cm -1 、1365cm -1 It is the antisymmetric and symmetric stretching vibration peak of SO2, 1074cm -1 and 946cm -1 They are the stretching vibration peaks of S-OH and SC respectively. In the EGDMA spectrum, 1722 cm -1 It is the stretching vibration peak of C=O in the ester group, 1635cm -1 It is the C=C stretching vibration peak, 1154cm -1 is the stretching vibration peak of ester group CO. From the spectrum of PDAE hydrogel, we can see that 1724 and 1045 cm -1 The characteristic peaks in EGDMA are 1615, 1448, 1363 and 1262 cm -1 may be the characteristic peaks of DEA, and 1074cm -1 It is the characteristic peak of AMPS.

[0028] TG analysis of PDAE

[0029] Thermogravimetric analysis of freeze-dried PDAE1-PDAE7 was performed, and the results are shown in Figure 3 .

[0030] from Figure 3 It can be seen that the thermal degradation of PDAE is mainly divided into three stages. First, in the first stage, the weight loss occurs below 100°C, and the mass loss is 5% to 10%, which is due to the degradation of physically adsorbed water; the second stage weight loss occurs between 200°C and 330°C, and the mass loss is 10% to 30%, which is because the PDAE main chain skeleton is decomposed and the cross-linked network is decomposed into small molecules. The third stage weight loss is from 330°C to 440°C, and the mass loss is 70% to 90%, which is because the small molecule monomer is degraded, releasing a large amount of CO2, water, ammonia, -SO3H degraded SO2 and nitrile, and it can be found that the larger the proportion of AMPS, the less the remaining mass of the polymer main chain at 600°C.

[0031] SEM analysis of PDAE

[0032] If PDAE is dried by vacuum, the gel will lose water and cause structural damage or collapse, thus affecting the experimental results. Therefore, the pores of the gel can be better preserved by vacuum freeze drying.

[0033] 1) Effect of different monomer contents on gel morphology

[0034] Scanning electron microscopy (SEM) was used to analyze the morphology of freeze-dried PDAE1-PDAE5. Figure 4 shown.

[0035] From the SEM images, we can see that the three-dimensional network structures of the five PDAEs are obvious and interconnected, which provides a channel for water molecules to enter the gel. In addition, the pore size of PDAE1 to PDAE5 gradually increases with the increase of the AMPS ratio. Because when the AMPS ratio increases, the proportion of hydrophilic groups (-SO3H) on the polymer chain also increases accordingly, and a large number of sulfonic acid groups produce hydrogen bonds with external water molecules. At the same time, the proportion of ethyl groups inside the gel decreases, and the hydrophobicity of PDAE decreases, which increases the distance between polymer molecules and makes it easier for water molecules to enter the cross-linked network, resulting in a larger pore size after freeze-drying.

[0036] 2) Effect of cross-linking agent content on the surface morphology of PDAE

[0037] The morphology of the three materials PDAE5~PDAE7 with different crosslinking agent contents was observed by SEM. Figure 5 shown.

[0038] As can be seen from the figure, the pore size of the cross-linked network gradually decreases with the increase of the cross-linking agent content. This is because as the cross-linking density in the cross-linked network system increases, the mobility of water molecules in the cross-linked structure decreases, making it difficult for them to contact with the hydrophilic groups to form hydrogen bonds, so the pore size of PDAE gradually decreases.

[0039] Porosity analysis of PDAE

[0040] Porosity refers to the percentage of voids in a solid. The solvent diffusion rate depends on the porosity. The porosity analysis results are shown in Figure 6It can be seen that the porosity of PDAE is in the range of 38-47%. The porosity of the five materials PDAE1-PDAE5 gradually increases with the increase of AMPS content, and the content of hydrophilic groups in the polymer network increases. From the SEM image, it can be seen that as the pore size of PDAE increases, it is easier for water molecules to enter and exit the three-dimensional network, so the porosity increases. The porosity of PDAE5-PDAE7 decreases with the increase of cross-linker content. The increase of cross-linker content makes the polymer network structure more compact, the gel pore size becomes smaller, and the porosity decreases, which is consistent with the results of electron microscopy analysis.

[0041] Analysis of swelling properties of PDAE

[0042] 1) Study on the swelling kinetics of PDAE

[0043] The freeze-dried PDEA1-PDEA7 was placed in deionized water at 25°C for swelling kinetics testing. This method can eliminate the interference of temperature and ion concentration on the swelling rate of the gel. The results are shown in Figure 7 .

[0044] from Figure 7 It can be seen that the swelling rate of PDAE increased rapidly in the first 4 h, and the swelling rate increased slowly from 4 h to 8 h. After 8 h, the swelling rate of the hydrogel reached equilibrium. The equilibrium swelling rates of the seven hydrogels PDAE1-PDAE7 were 7.2 g·g -1 , 14.4 g·g -1 , 20.0g·g -1 , 23.5g·g -1 , 29.2g·g -1 , 24.5g·g -1 , 20.1g·g -1 . It can be seen that in the PDAE1~PDAE5 gel system, the higher the AMPS content, the greater the swelling rate of the gel. A large number of sulfonic acid groups are deprotonated in deionized water to generate a large amount of negative charges. The repulsive force between charges of the same kind makes the gel network structure loose and the pore size larger, which provides convenient conditions for water molecules to enter and exit the gel network, increasing the swelling rate of the gel. This is consistent with the results of electron microscopy and mechanical properties analysis of PDAE. The higher the AMPS ratio, the larger the pore size of the gel, the lower the mechanical strength, and the higher the equilibrium swelling rate. The swelling rate of PDAE5~PDAE7 hydrogels decreases with the increase of cross-linking agent content. The cross-linking density in the gel system increases, which makes the gel pore size smaller and hinders the entry and exit of water molecules into the gel network, so the swelling rate decreases.

[60] .

[0045] 2) Study on temperature sensitivity of PDAE

[0046] N,N-diethylacrylamide (DEA) contains a hydrophobic carbon-hydrogen skeleton and a hydrophilic amide group in its molecular structure. It is an acrylamide derivative monomer with good biocompatibility and temperature sensitivity. Because only the crosslinker content in PDAE6 and PDAE7 changed, the temperature sensitivity test only tested PDAE1-PDAE5. The equilibrium swelling rates of the five PDAEs were analyzed at different temperatures. The results are shown in Figure 8 .

[0047] Depend on Figure 8 It can be seen that the equilibrium swelling rates of PDAE1~PDAE5 gels at different temperatures have the same trend of change, and all decrease with increasing temperature. The lower critical solution temperature (LCST) of DEA is 32°C. Below LCST, the internal interactions of polymer molecular chains are weak, and the strong hydrogen bonds between hydrophilic groups and water molecules cause the gel to expand and the equilibrium swelling rate to increase; above LCST, the interactions within the polymer network are strong, and the hydrogen bonds with water molecules are weakened, the gel volume collapses or shrinks, and the equilibrium swelling rate of the gel decreases.

[0048] 3) Study on pH sensitivity of PDAE

[0049] The pH environment has a great influence on the swelling behavior of the prepared hydrogels. The presence of ionizable groups in the polymer network affects the swelling of the hydrogels. Since only the crosslinker content changes in PDAE6 and PDAE7, the pH sensitivity test only tests PDAE1 to PDAE5. The swelling rate test results of the five hydrogels in deionized water with pH values ​​of 1.2 and 7.4 are shown in Fig. 9 .

[0050] from Fig. 9 It can be seen that the swelling rates of the five hydrogels in solutions with different pH values ​​are significantly different. Compared with pH 1.2, the swelling rate of the gel in an environment with a pH of 7.4 is higher, and the stronger the swelling ability, the more obvious the difference. The swelling rate of the hydrogel depends on the degree of relaxation of the side chain functional groups and polymer chains in the cross-linked network. The sulfonic acid groups in AMPS can be protonated and deprotonated in acidic and alkaline environments. In an environment with a pH of 1.2, the sulfonic acid groups in AMPS are protonated, resulting in a large hydrogen bond force between the gel structure, a very tight gel structure, and a small swelling rate; while in an environment with a pH of 7.4, the sulfonic acid groups are deprotonated, causing the gel to carry a negative charge, and the electrostatic repulsion increases the pore size in the gel network, making it easy for water molecules to enter the network. On the other hand, the hydrogen bonds inside the gel are broken, and the hydrogen bonding between the hydrophilic monomer AMPS and external water molecules is enhanced, so the swelling rate is greater at a pH of 7.4.

[0051] The contents of AMPS and the crosslinking agent both affect the pore size, porosity, compressive strength, and swelling ability of PDAE. As the proportion of AMPS in the molecular structure increases, the average pore size and porosity of PDAE increase. Consequently, the equilibrium swelling ratio of the gel increases, and the compressive strength decreases. When the molar ratio of DEA to AMPS is 121:9, the porosity is maximally 47.59%, and the swelling ratio is maximally 29.2 g·g -1 , and the compressive strength is 97.76 kPa. As the content of the crosslinking agent in the system increases, the crosslinking density of the polymer network increases, the gel pore size and porosity decrease, the gel equilibrium swelling ratio decreases, and the compressive strength increases. When the content of the crosslinking agent is 0.4 g, the porosity is 38.85%, and the swelling ratio is 20.1 g·g -1 , and the compressive strength is 155.96 kPa.

[0052] 2) PDAE1 to PDAE5 have certain temperature and pH sensitivities and ion responsiveness. In solutions at different temperatures, the equilibrium swelling ratios of the five PDAEs all decrease with increasing temperature. At the same temperature, the swelling ratio order of PDAE is PDAE1 < PDAE2 < PDAE3 < PDAE4 < PDAE5; the swelling ratios of PDAE1 to PDAE5 at pH 7.4 are all greater than those at pH 1.2, and at the same pH value, the swelling ratio order of the gel is PDAE1 < PDAE2 < PDAE3 < PDAE4 < PDAE5.

[0053] Drug loading performance study of PDAE

[0054] The drug loading amounts and encapsulation efficiencies of PDAE1 to PDAE7 gels for 5-Fu are as Fig.10 shown. The hydrogel encapsulates drugs by the solution diffusion method. As can be seen from the figure, the drug loading amount and encapsulation efficiency of the hydrogel are consistent with the strength of its swelling performance. The drug loading amounts of the seven gels are 124.91 mg·g -1 , 159.11 mg·g -1 , 201.84 mg·g -1 , 236.43 mg·g -1 , 326.84 mg·g -1 , 270.92 mg·g -1 , 222.67 mg·g- 1 , and the encapsulation efficiencies are 6.99%, 8.63%, 9.81%, 11.97%, 16.72%, 14.72%, and 11.60% respectively. For the subsequent drug release process, we select PDAE5 with the highest drug loading amount and encapsulation efficiency as the research object.

[0055] Drug release performance study of 5-Fu@PDAE5

[0056] The release performance of 5-Fu@PDAE5 was tested at the same temperature (37°C) and pH value (pH=7.4 and pH=1.2). Fig.11 .

[0057] from Fig.11 It can be seen that in the dilution medium under different conditions, the rate of drug release from the gel is fast at the beginning, then slows down, and finally reaches equilibrium. This is because the gel initially releases the drug molecules on the surface of the gel, so the release rate is fast. Subsequently, the drug concentration in the gel gradually decreases, the drug concentration in the dilution medium gradually increases, and the drug concentration gradient between the gel and the dilution medium also gradually decreases. The driving force of the drug concentration difference weakens, so the drug release rate becomes slower and slower until equilibrium is reached.

[0058] The cumulative drug release rate of 5-Fu@PDAE5 in a dilution medium with a pH value of 1.2 for 14 hours is 9.14%, and the cumulative drug release rate in a dilution medium with a pH value of 7.4 for 14 hours is 26.34%. It can be seen that the cumulative drug release rate in a dilution medium with a pH value of 7.4 is higher than that in a dilution medium with a pH value of 1.2. This is because 5-Fu is a negative ion drug, and the gel carries a negative charge in a dilution medium with a pH value of 7.4. The repulsion of the same charges accelerates the release of 5-Fu, while in a dilution medium with a pH value of 1.2, there is a strong hydrogen bond between the drug and the gel, and it is not easy to release from the gel.

[0059] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the present invention.

Claims

1. A method for preparing a temperature / pH responsive hydrogel PDAE, characterized in that: The preparation of one unit of the gel in proportion comprises the following steps: DEA and AMPS with a certain sum of the amounts of substances were dissolved in 4 mL of deionized water, and EGDMA was dissolved in 4 mL of anhydrous ethanol. The two solutions were mixed and ultrasonically dispersed evenly, and then placed in an ice bath; then the APS / TEMED composite initiator was slowly added, mixed evenly, and transferred to a vacuum needle tube, and fully reacted in a water bath at 45°C for 12 h; after the polymerization reaction was completed, the hydrogel was slowly pushed out with a piston, and then cut into cylindrical gel blocks with a thickness of 3 mm. The gel blocks were soaked in deionized water for 72 h, and the water was changed every 8 h to remove unreacted monomers in the system, and then freeze-dried for 48 h.

2. The method for preparing the temperature / pH responsive hydrogel PDAE according to claim 1, characterized in that: The sum of the amounts of DEA and AMPS substances is 130 mol.

3. The method for preparing the temperature / pH responsive hydrogel PDAE according to claim 2, characterized in that: The specific dosage of each component is: DEA:AMPS is 121 mol:9 mol; EGDMA is 0.3 g; APS is 50 mg; TEMED is 60 μL.

4. Temperature / pH responsive hydrogel PDAE combined with 5-fluorouracil, application of 5-Fu@PDAE5 in drug release.